Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Data Validation

Data Validation

Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Sensitivity, Specificity, and Predicted Value

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

Receiver Operating Characteristic Plot

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Temporal External Validation of a Customized Fetal Body Mass Index Percentile Model for Neonatal Nutritional Status Assessment.

Diagnostics (Basel, Switzerland)·2026

Same author

Nucleic acids in pleural fluid for the etiological diagnosis of pleural effusion.

Translational lung cancer research·2025

Same author

Pleural fluid biomarkers for the diagnosis and management of malignant pleural effusions: a clinical review.

Critical reviews in clinical laboratory sciences·2025

Same author

Pleural Fluid Biomarkers of Pediatric Parapneumonic Effusion.

Diagnostics (Basel, Switzerland)·2025

Same author

Customized Fetal Body Mass Index as a Better Predictive Marker for Neonatal Nutritional Status.

Diagnostics (Basel, Switzerland)·2025

Same author

New spin coated multilayer lactate biosensor for acidosis monitoring in continuous flow assisted with an electrochemical pH probe.

Mikrochimica acta·2024

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

External Validation of a Predictive Model for Thyroid Cancer Risk with Decision Curve Analysis.

Juan Jesús Fernández Alba^1,2, Florentino Carral³, Carmen Ayala Ortega³

¹Department of Obstetrics and Gynaecology, University Hospital of Puerto Real, 11-510 Cadiz, Spain.

Diagnostics (Basel, Switzerland)

|March 28, 2025

Summary

This study validates a predictive model for thyroid nodule malignancy risk. The model accurately distinguishes benign from malignant nodules, aiding clinical decisions and reducing unnecessary procedures.

Keywords:

artificial intelligence (AI)decision curve analysis diagnostic tools external validation machine learning (ML)papillary thyroid carcinoma (PTC)predictive model thyroid cancer thyroid nodules

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 12, 2026

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

Endocrinology
Oncology
Medical Imaging

Background:

Thyroid cancer incidence, particularly papillary thyroid carcinoma (PTC), is rising.
Increased detection of subclinical cancers is linked to advanced imaging and fine-needle aspiration.
External validation of a predictive model for thyroid nodule malignancy risk is needed.

Purpose of the Study:

To externally validate a previously developed predictive model for thyroid nodule malignancy.
To assess the model's performance in a distinct patient cohort.
To determine the clinical utility of the model through decision curve analysis.

Main Methods:

Utilized clinical, analytical, ultrasound, and histological data from 455 patients.
Evaluated the predictive model's performance on a new dataset.
Conducted decision curve analysis to ascertain clinical utility.

Main Results:

98 out of 455 patients (21.54%) had malignant tumors, predominantly papillary cancer (71.4%).
Malignant nodules showed specific characteristics: solid (95.9%), hypoechogenic (72.4%), irregular borders (36.7%), and suspicious lymph nodes (24.5%).
Decision curve analysis confirmed the model's accuracy and clinical impact.

Conclusions:

The predictive model is robust and generalizable across different settings.
AI and ML models enhance accuracy in differentiating benign from malignant nodules.
Optimized treatment strategies, reduced invasive procedures, and lowered healthcare costs are potential benefits.